| Enalapril |
II-0177/06.07.2007 |
Berlipril, Tablet, 5, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
2.72 |
0.54 |
3.26 |
7% |
0.19 |
2.91 |
0.58 |
3.49 |
20% |
0.54 |
3.45 |
0.69 |
4.14 |
промяна на обстоятелства НСР-4465/15.08.2014( в сила от 01.09.2014) |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
27 |
| Enalapril |
20020460 |
Berlipril, Tablet, 10, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
3.03 |
0.61 |
3.64 |
7% |
0.21 |
3.24 |
0.65 |
3.89 |
20% |
0.61 |
3.85 |
0.77 |
4.62 |
корекционно решение НСР-6578/01.07.2015, промяна обстоятелства НСР-9894/29.07.2016 |
НСР-6499/18.06.2015 |
04.07.2015 |
02.09.2016 |
Активен |
28 |
| Enalapril |
II-0178/06.07.2007 |
Berlipril, Tablet, 10, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
3.03 |
0.61 |
3.64 |
7% |
0.21 |
3.24 |
0.65 |
3.89 |
20% |
0.61 |
3.85 |
0.77 |
4.62 |
корекционно решение НСР-6578/01.07.2015 |
НСР-6499/18.06.2015 |
04.07.2015 |
04.07.2015 |
Неактивен |
28 |
| Enalapril |
II-0179/06.07.2007 |
Berlipril, Tablet, 20, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
5.2 |
1.04 |
6.24 |
7% |
0.36 |
5.56 |
1.11 |
6.67 |
20% |
1.04 |
6.6 |
1.32 |
7.92 |
промяна на обстоятелства НСР-4529/22.08.2014( в сила от 08.09.2014) |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
29 |
| Enalapril |
II-0178/06.07.2007 |
Berlipril, Tablet, 10, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
3.09 |
0.62 |
3.71 |
7% |
0.22 |
3.31 |
0.66 |
3.97 |
20% |
0.62 |
3.93 |
0.79 |
4.72 |
промяна на обстоятелства НСР-4466/15.08.2014( в сила от 01.09.2014) |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
28 |
| Inotuzumab ozogamicin |
EU/1/17/12 00/001 |
BESPONSA, Powder for concentrate for solution for infusion, 1, mg, Pack: 1 vial |
Pfizer Europe MA EEIG, Белгия |
Pfizer Ireland Pharmaceuticals, Ирландия |
18635.85 |
3727.17 |
22363.02 |
4% |
10 |
18645.85 |
3729.17 |
22375.02 |
16% |
25 |
18670.85 |
3734.17 |
22405.02 |
|
НСР-17555/19.12.2018 предварително изпълнение |
19.12.2018 |
02.01.2019 |
Активен |
16071 |
| Metoprolol |
20100091 |
BETABLOCKADE, Prolonged release tablet, 100, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД гр. Пловдив, България |
6.92 |
1.38 |
8.3 |
7% |
0.48 |
7.4 |
1.48 |
8.88 |
20% |
1.38 |
8.78 |
1.76 |
10.54 |
|
НСР-3869/20.06.2014; НСР-18110/07.03.2019 |
22.03.2019 |
02.04.2019 |
Активен |
2952 |
| Metoprolol |
20100091 |
BETABLOCKADE, Prolonged release tablet, 100, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД гр. Пловдив, България |
6.57 |
1.31 |
7.88 |
7% |
0.46 |
7.03 |
1.41 |
8.44 |
20% |
1.31 |
8.34 |
1.67 |
10.01 |
|
НСР-3869/20.06.2014 |
04.07.2014 |
04.07.2014 |
Неактивен |
2952 |
| Metoprolol |
20100090 |
BETABLOCKADE, Prolonged release tablet, 50, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД гр. Пловдив, България |
4.94 |
0.99 |
5.93 |
7% |
0.35 |
5.29 |
1.06 |
6.35 |
20% |
0.99 |
6.28 |
1.26 |
7.54 |
|
НСР-3869/20.06.2014; НСР-18108/07.03.2019 |
22.03.2019 |
02.04.2019 |
Активен |
2953 |
| Metoprolol |
20100090 |
BETABLOCKADE, Prolonged release tablet, 50, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД гр. Пловдив, България |
4.69 |
0.94 |
5.63 |
7% |
0.33 |
5.02 |
1 |
6.02 |
20% |
0.94 |
5.96 |
1.19 |
7.15 |
|
НСР-3869/20.06.2014 |
04.07.2014 |
04.07.2014 |
Неактивен |
2953 |
| Metoprolol |
ІІ-6929/11.02.2010 |
BETABLOCKADE, Prolonged release tablet, 100, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД гр. Пловдив, България |
6.16 |
1.23 |
7.39 |
7% |
0.43 |
6.59 |
1.32 |
7.91 |
20% |
1.23 |
7.82 |
1.56 |
9.38 |
|
КЦ-1490/09.04.2010 |
03.05.2010 |
03.05.2010 |
Неактивен |
2952 |
| Metoprolol |
ІІ-6928/11.02.2010 |
BETABLOCKADE, Prolonged release tablet, 50, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД гр. Пловдив, България |
4.4 |
0.88 |
5.28 |
7% |
0.31 |
4.71 |
0.94 |
5.65 |
20% |
0.88 |
5.59 |
1.12 |
6.71 |
|
КЦ-1490/09.04.2010 |
03.05.2010 |
03.05.2010 |
Неактивен |
2953 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 vials + 15 pre-filled syringe |
Bayer AG, Германия |
Bayer AG, Германия |
1158.3 |
231.66 |
1389.96 |
4% |
10 |
1168.3 |
233.66 |
1401.96 |
16% |
25 |
1193.3 |
238.66 |
1431.96 |
промяна на обстоятелства НСР-9273/05.05.2016; НСР-13536/18.08.2017 |
НСР-5755/26.02.2015.; НСР-9117/27.04.2016; НСР-13275/20.07.2017; НСР-16880/28.09.2018 |
13.10.2018 |
02.11.2018 |
Активен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 vials + 15 pre-filled syringe |
Bayer AG, Германия |
Bayer AG, Германия |
1171.17 |
234.23 |
1405.4 |
4% |
10 |
1181.17 |
236.23 |
1417.4 |
16% |
25 |
1206.17 |
241.23 |
1447.4 |
промяна на обстоятелства НСР-9273/05.05.2016; НСР-13536/18.08.2017 |
НСР-5755/26.02.2015.; НСР-9117/27.04.2016; НСР-13275/20.07.2017 |
04.08.2017 |
02.10.2017 |
Неактивен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 vials + 15 pre-filled syringe |
Bayer AG, Германия |
Bayer AG, Германия |
1171.17 |
234.23 |
1405.4 |
4% |
10 |
1181.17 |
236.23 |
1417.4 |
16% |
25 |
1206.17 |
241.23 |
1447.4 |
промяна на обстоятелства НСР-9273/05.05.2016; НСР-13536/18.08.2017 |
НСР-5755/26.02.2015.; НСР-9117/27.04.2016; НСР-13275/20.07.2017 |
04.08.2017 |
02.10.2017 |
Неактивен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 vials + 15 pre-filled syringe |
Bayer Pharma AG, Германия |
Bayer Pharma AG 13342 Berlin, Germany |
1171.17 |
234.23 |
1405.4 |
4% |
10 |
1181.17 |
236.23 |
1417.4 |
16% |
25 |
1206.17 |
241.23 |
1447.4 |
промяна на обстоятелства НСР-9273/05.05.2016 |
НСР-5755/26.02.2015.; НСР-9117/27.04.2016; НСР-13275/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 vials + 15 pre-filled syringe |
Bayer Pharma AG, Германия |
Bayer Pharma AG 13342 Berlin, Germany |
1193.64 |
238.73 |
1432.37 |
4% |
10 |
1203.64 |
240.73 |
1444.37 |
16% |
25 |
1228.64 |
245.73 |
1474.37 |
промяна на обстоятелства НСР-9273/05.05.2016 |
НСР-5755/26.02.2015.; НСР-9117/27.04.2016 |
02.06.2016 |
02.06.2016 |
Неактивен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Bayer Schering Pharma AG,, Германия |
Bayer Pharma AG 13342 Berlin, Germany |
1238.26 |
247.65 |
1485.91 |
4% |
10 |
1248.26 |
249.65 |
1497.91 |
16% |
25 |
1273.26 |
254.65 |
1527.91 |
|
НСР-5755/26.02.2015. |
12.03.2015 |
12.03.2015 |
Неактивен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Bayer Schering Pharma AG,, Германия |
Bayer Pharma AG 13342 Berlin, Germany |
1279.58 |
255.92 |
1535.5 |
4% |
10 |
1289.58 |
257.92 |
1547.5 |
16% |
25 |
1314.58 |
262.92 |
1577.5 |
|
НСР-2256/21.12.2013 |
28.01.2014 |
28.01.2014 |
Неактивен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Bayer Pharma AG, Германия |
Bayer Pharma AG 13342 Berlin, Germany |
1501.84 |
300.37 |
1802.21 |
4% |
10 |
1511.84 |
302.37 |
1814.21 |
16% |
25 |
1536.84 |
307.37 |
1844.21 |
|
КЦРР-2959/20.03.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
3629 |
| Interferon beta-1b |
EU/1/95/003/003 |
Betaferon, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Bayer Schering Pharma AG,, Германия |
Bayer Schering Pharma AG, Germany |
1639.2 |
327.84 |
1967.04 |
4% |
10 |
1649.2 |
329.84 |
1979.04 |
16% |
25 |
1674.2 |
334.84 |
2009.04 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
3629 |
| Metoprolol |
20050462 |
BETALOC ZOK, Prolonged release tablet, 100, mg, Pack: 28 |
Astra Zeneca AB, Швеция |
Astra Zeneca AB Sweden |
7.31 |
1.46 |
8.77 |
7% |
0.51 |
7.82 |
1.56 |
9.38 |
20% |
1.46 |
9.28 |
1.86 |
11.14 |
|
НСР-9395/01.06.2016.; НСР-13781/12.09.2017; НСР-17262/14.11.2018 |
29.11.2018 |
02.12.2018 |
Активен |
3596 |
| Metoprolol |
20050462 |
BETALOC ZOK, Prolonged release tablet, 100, mg, Pack: 28 |
Astra Zeneca AB, Швеция |
Astra Zeneca AB Sweden |
7.39 |
1.48 |
8.87 |
7% |
0.52 |
7.91 |
1.58 |
9.49 |
20% |
1.48 |
9.39 |
1.88 |
11.27 |
|
НСР-9395/01.06.2016.; НСР-13781/12.09.2017 |
27.09.2017 |
02.10.2017 |
Неактивен |
3596 |
| Metoprolol |
99000024 |
BETALOC ZOK, Prolonged release tablet, 50, mg, Pack: 28 |
Astra Zeneca AB, Швеция |
Astra Zeneca AB, Sweden |
5.85 |
1.17 |
7.02 |
7% |
0.41 |
6.26 |
1.25 |
7.51 |
20% |
1.17 |
7.43 |
1.49 |
8.92 |
Протокол №240/31.08.2017 |
НСР-5678/18.02.2015.; НСР-15686/17.05.2018 |
01.06.2018 |
02.06.2018 |
Активен |
3595 |
| Metoprolol |
99000024 |
BETALOC ZOK, Prolonged release tablet, 50, mg, Pack: 28 |
Astra Zeneca AB, Швеция |
Astra Zeneca AB, Sweden |
6.22 |
1.24 |
7.46 |
7% |
0.44 |
6.66 |
1.33 |
7.99 |
20% |
1.24 |
7.9 |
1.58 |
9.48 |
Протокол №240/31.08.2017 |
НСР-5678/18.02.2015. |
05.03.2015 |
02.09.2017 |
Неактивен |
3595 |